These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. II. Activation of B cells by cross-linkage or aggregation of the TRF acceptor molecule.
    Author: Tominaga A, Takatsu K, Hamaoka T.
    Journal: J Immunol; 1982 Jun; 128(6):2581-5. PubMed ID: 6978908.
    Abstract:
    An in vitro experimental system was established to demonstrate the TRF-substituting activity of an alloantiserum raised in TRF low-responder (DBA2/2Ha x BALB/c)(DC)F, male mice against TRF high-responder parental BALB/c B cells. The TRF substituting activity of the antiserum was apparent in that anti-Thy-1 plus C-treated, DNP-primed B cells from TRF high-responder mice were effectively stimulated, whereas B cells from TRF low-responder DBA/2Ha mice were not, as evidenced by the induction of secondary anti-DNP IgG PFC responses. The specificity of the reaction of the antibody with a component present on the TRF high-responder B cells was also substantiated by the fact that antibody activity was virtually eliminated by absorption with B cells from various TRF high-responder mice but not by TRF low-responder DBA/2Ha B cells. The IgG fraction of antiserum and the F(ab')2 and Fab' fragments of the antibody, which possess a comparable reactivity in regard to the TRF acceptor site(s), were prepared, and analysis of the B cell-triggering mechanism by the antibody was carried out. The results revealed that both the IgG fraction and F(ab')2 fragment, but not the monovalent Fab' fragment, demonstrated effective TRF-substituting activity, indicating that cross-linkage or aggregation of the TRF acceptor site(s) may give rise to differentiation signals to the B cells.
    [Abstract] [Full Text] [Related] [New Search]